Delivery Order SPE2DB24D3013-SPE2DB25FFJQQ

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,002.72 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a medication. There is no set-aside designation for this contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
The U.S. government agency Defense Logistics Agency (DLA) awarded a $1,729.00 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through February 18, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a medical product, with a ceiling value of $2,906.88 and a completion date of January 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This is a $1,671.20 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication, to support federal healthcare requirements. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120MG/ML 1S medication. The contract has a ceiling value of $1,210.30 and a performance period through February 11, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,280.79, is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a ceiling value of $2,361.84 and a completion date of December 27, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,398.54 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide EMGALITY 120 MG/ML PENML medication. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,897.69, is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.50 firm-fixed-price delivery order is for EMGALITY 120MG/ML 1S, a medical supply product, with a completion date of January 9, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFJQQ
    Delivery Order

This is a $1,872.01 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML syringes, with a period of performance through February 2025.

The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:58 AM